139 related articles for article (PubMed ID: 36199787)
1. Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx.
Johnson L; Ha DT; Hall MB; Shoemaker G; Bevins PA; Strickley J; Demehri S; Redman RA; Joh J
J Oncol; 2022; 2022():3107990. PubMed ID: 36199787
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer.
Smith EM; Pawlita M; Rubenstein LM; Haugen TH; Hamsikova E; Turek LP
Int J Cancer; 2010 Jul; 127(1):111-7. PubMed ID: 19876924
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus seropositivity and risks of head and neck cancer.
Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
[TBL] [Abstract][Full Text] [Related]
4. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
bioRxiv; 2023 Nov; ():. PubMed ID: 37961092
[TBL] [Abstract][Full Text] [Related]
5. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?
Smith EM; Rubenstein LM; Ritchie JM; Lee JH; Haugen TH; Hamsikova E; Turek LP
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2087-96. PubMed ID: 18708401
[TBL] [Abstract][Full Text] [Related]
6. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
9. Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas.
Oton-Gonzalez L; Rotondo JC; Lanzillotti C; Mazzoni E; Bononi I; Iaquinta MR; Cerritelli L; Malagutti N; Ciorba A; Bianchini C; Pelucchi S; Tognon M; Martini F
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282779
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
[TBL] [Abstract][Full Text] [Related]
11. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.
Huang CG; Lee LA; Liao CT; Yen TC; Yang SL; Liu YC; Li JC; Gong YN; Kang CJ; Huang SF; Fang KH; Chang KP; Lee LY; Hsueh C; Shih SR; Tsao KC
Oncotarget; 2017 May; 8(21):34820-34835. PubMed ID: 28422732
[TBL] [Abstract][Full Text] [Related]
12. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study.
Rubenstein LM; Smith EM; Pawlita M; Haugen TH; Hamšíková E; Turek LP
Infect Agent Cancer; 2011 Jul; 6():9. PubMed ID: 21740566
[TBL] [Abstract][Full Text] [Related]
14. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
[TBL] [Abstract][Full Text] [Related]
15. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
16. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
Gheit T; Anantharaman D; Holzinger D; Alemany L; Tous S; Lucas E; Prabhu PR; Pawlita M; Ridder R; Rehm S; Bogers J; Maffini F; Chiocca S; Lloveras B; Kumar RV; Somanathan T; de Sanjosé S; Castellsagué X; Arbyn M; Brennan P; Sankaranarayanan R; Pillai MR; Gangane N; Tommasino M;
Int J Cancer; 2017 Jul; 141(1):143-151. PubMed ID: 28369859
[TBL] [Abstract][Full Text] [Related]
17. Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer.
Huang CC; Su YC; Chang CC; Lee WT; Ou CY; Wu YH; Wu SY; Lai YH; Huang JS; Chen KC; Hsueh WT; Tsai ST; Yen CJ; Chang JY; Tsai ML; Lin CL; Weng YL; Yang HC; Chen YS; Hsiao JR; Chang JS
Cancer Med; 2021 Jun; 10(12):4075-4086. PubMed ID: 33949155
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
Eytan DF; Blackford AL; Eisele DW; Fakhry C
Cancer; 2019 Jan; 125(2):249-260. PubMed ID: 30444527
[TBL] [Abstract][Full Text] [Related]
19. A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).
Chandra J; Woo WP; Finlayson N; Liu HY; McGrath M; Ladwa R; Brauer M; Xu Y; Hanson S; Panizza B; Frazer IH; Porceddu SV
Cancer Immunol Immunother; 2021 Mar; 70(3):743-753. PubMed ID: 32918586
[TBL] [Abstract][Full Text] [Related]
20. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
